Ardelyx Gets IBS-C Approval, But Focus Remains On Hyperphosphatemia

 
• By Joseph Haas
  
FDA Approved text on medical doctor blur lights background. - Image
Ardelyx got its first drug approval, but has no plans to launch Ibsrela on its own • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip